Sanara MedTech Inc. (SMTI) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Sanara MedTech Inc. (SMTI): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 46/100 — a percentile rank of Sanara MedTech Inc.’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $320.5M |
| P / S | 2.9× |
| EV / EBITDA | 26.7× |
| Gross margin | 93.0% |
| Operating margin | 7.7% |
| Net margin | -29.2% |
| Return on equity | -403.0% |
| ROIC | 21.3% |
| Revenue growth | 13.0% |
| Debt / equity | 5.9× |
| Dividend yield | 0.0% |
Is Sanara MedTech Inc. overvalued? P/S looks fair vs its 5-year range; P/B looks overvalued vs its 5-year range.
Independent of the events above — derived from Sanara MedTech Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact